Rakesh Jain, MD, MPH

Psych Congress 2026

September 15–19, 2026 · New Orleans, LA · Full program

• CourseAdvanced Psychopharmacology Intensive: Emerging Neurobiologic Targets and Metabolic Pathways Reshaping Psychiatric Treatment

  September 15, 2026

  Half-day ticketed intensive built around four expert-led modules on treatment mechanisms moving beyond monoamines: orexin-based agents, glutamate/dopamine circuit approaches, muscarinic receptor modulation, and GLP-1/bioenergetic pathways.

  GLP-1 & Metabolic PsychiatryMuscarinic & Novel AntipsychoticsNeuroscience & MechanismsDrug Pipeline & Clinical Trials

• DebatePsychedelic Therapy After the Executive Order: Now What?

  September 15, 2026

  Opening-afternoon multidisciplinary panel pairing a patient's lived-experience story with a policy update on how the recent executive order and existing regulatory frameworks may shape near-term clinical use of psychedelic therapies.

  Practice, Policy & WorkforcePsychedelics

• SymposiumSolving Clinical Challenges: Untangling Sleep Problems in Psychiatric Practice

  September 16, 2026

  Case-based session on sorting whether insomnia or hypersomnia reflects medication effects, primary sleep disorders, circadian disruption, or worsening psychiatric illness, and when to order sleep studies. Developed with the Sleep Research Society Foundation.

  Drug Interactions & SafetySleep & Insomnia

• SymposiumLatest Discoveries & Emerging Trends in MDD

  September 17, 2026

  Year-in-review of depression research spanning neurobiology, trial results, and pharmacologic and non-pharmacologic innovation, with selected poster presenters showcasing new data.

  DepressionNeuroscience & MechanismsDrug Pipeline & Clinical Trials

• SymposiumWhen Anxiety Persists: Evidence-Based Strategies and Novel Pharmacologic Options Beyond First-Line Treatment

  September 17, 2026

  Step-by-step framework for treatment-resistant anxiety after SSRI/SNRI failure, covering sequencing, psychotherapy integration, and off-label and emerging agents from gabapentinoids to glutamatergic and GABAergic options.

  Anxiety DisordersDrug Pipeline & Clinical TrialsPsychotherapy

• SymposiumFirst-Line Decisions: Lifestyle Modification or Medication? Early Treatment Pathways for PTSD

  September 19, 2026

  Guides the choice between trauma-focused psychotherapies (CPT, Prolonged Exposure) and pharmacotherapy (SSRIs, SNRIs, prazosin) in early PTSD care, alongside sleep stabilization and grounding skills.

  PsychotherapyPTSD & TraumaSleep & Insomnia

• PlenaryCultivating Clinical Wisdom in Deprescribing - Practical Considerations for Psychiatry

  September 19, 2026

  Closing session on when and how to reduce psychotropic regimens: identifying candidates, shared decision-making, and safe tapering while weighing relapse and withdrawal risks.

  Deprescribing & Polypharmacy